These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 24161016)

  • 21. Analysis of combined detection of N-terminal pro-B-type natriuretic peptide and left ventricular ejection fraction in heart function in patients with acute CO poisoning.
    Liu SD; Shen Q; Lv C; Zhang P; Yu H; Yang L; Wu L
    Am J Emerg Med; 2014 Oct; 32(10):1212-4. PubMed ID: 25151325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro brain natriuretic peptide as a cardiac biomarker in Japanese hemodialysis patients.
    Shimizu M; Doi S; Nakashima A; Naito T; Masaki T
    Int J Artif Organs; 2018 Mar; 41(3):135-143. PubMed ID: 29546814
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction of N terminal-pro-brain (B-type) natriuretic peptide levels with exercise-based cardiac rehabilitation in patients with left ventricular dysfunction after myocardial infarction.
    Giallauria F; De Lorenzo A; Pilerci F; Manakos A; Lucci R; Psaroudaki M; D'Agostino M; Del Forno D; Vigorito C
    Eur J Cardiovasc Prev Rehabil; 2006 Aug; 13(4):625-32. PubMed ID: 16874155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiac function in survivors of acute lymphoblastic leukaemia and Hodgkin's lymphoma.
    Krawczuk-Rybak M; Dakowicz L; Hryniewicz A; Maksymiuk A; Zelazowska-Rutkowska B; Wysocka J
    J Paediatr Child Health; 2011 Jul; 47(7):455-9. PubMed ID: 21332587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of beta-blocker (carvedilol) therapy on N-terminal pro-brain natriuretic peptide levels and echocardiographic findings in patients with congestive heart failure.
    Gundogdu F; Bozkurt E; Kiziltunc A; Sevimli S; Arslan S; Gurlertop Y; Senocak H; Karakelleoglu S
    Echocardiography; 2007 Feb; 24(2):113-7. PubMed ID: 17313541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
    Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma NT-proBNP is a potential marker of disease severity and correlates with symptoms in patients with chronic rheumatic valve disease.
    Davutoglu V; Celik A; Aksoy M; Sezen Y; Soydinc S; Gunay N
    Eur J Heart Fail; 2005 Jun; 7(4):532-6. PubMed ID: 15921791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
    Park M; Vittinghoff E; Shlipak MG; Mishra R; Whooley M; Bansal N
    Am Heart J; 2014 Dec; 168(6):931-9.e2. PubMed ID: 25458658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Importance of plasma N-terminal pro B-type natriuretic peptide, epicardial adipose tissue, and carotid intima-media thicknesses in asymptomatic obese children.
    Saritas T; Tascilar E; Abaci A; Yozgat Y; Dogan M; Dundaroz R; Hasimi A; Yesilkaya E; Lenk MK; Kilic A
    Pediatr Cardiol; 2010 Aug; 31(6):792-9. PubMed ID: 20419296
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between NT-pro BNP levels and early mitral annulus velocity (E') in patients with non-ST-segment elevation acute coronary syndrome.
    Barbosa MM; Nunes Mdo C; Castro LR; Nominato LF; Alencar MC; Ribeiro AL
    Echocardiography; 2008 Apr; 25(4):353-9. PubMed ID: 18177379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-Terminal pro-B-Type Natriuretic Peptide Levels are Linked with Modified Child-Pugh Classification in Patients with Nonalcoholic Cirrhosis [NT-ProBNP and Liver Cirrhosis].
    Kumbasar A; Navdar M; Ataoglu E; Uzunhasan I; Ergen K; Poturoglu S; Basinoglu F; Yilmaz F; Yenigun M; Sar F; Tanriverdi O
    Cell Biochem Biophys; 2017 Mar; 75(1):111-117. PubMed ID: 27914003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of N-terminal Pro-B-type natriuretic peptide (NT-proBNP) in hemodialysis patients.
    Helal I; Belhadj R; Mohseni A; Bazdeh L; Drissa H; Elyounsi F; Abdallah TB; Abdelmoula J; Kheder A
    Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):262-8. PubMed ID: 20228511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.
    Betti I; Castelli G; Barchielli A; Beligni C; Boscherini V; De Luca L; Messeri G; Gheorghiade M; Maisel A; Zuppiroli A
    J Card Fail; 2009 Jun; 15(5):377-84. PubMed ID: 19477397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early trends in N-terminal pro-brain natriuretic peptide values after left ventricular assist device implantation for chronic heart failure.
    Hasin T; Kushwaha SS; Lesnick TG; Kremers W; Boilson BA; Schirger JA; Clavell AL; Rodeheffer RJ; Frantz RP; Edwards BS; Pereira NL; Stulak JM; Joyce L; Daly R; Park SJ; Jaffe AS
    Am J Cardiol; 2014 Oct; 114(8):1257-63. PubMed ID: 25194171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Kubánek M; Goode KM; Lánská V; Clark AL; Cleland JG
    Eur J Heart Fail; 2009 Apr; 11(4):367-77. PubMed ID: 19179406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of N-terminal pro-B-type natriuretic peptide in patients with active infective endocarditis.
    Kahveci G; Bayrak F; Mutlu B; Bitigen A; Karaahmet T; Sonmez K; Izgi A; Degertekin M; Basaran Y
    Am J Cardiol; 2007 May; 99(10):1429-33. PubMed ID: 17493474
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-terminal proBNP plasma levels correlate with severity of mitral stenosis.
    Iltumur K; Karabulut A; Yokus B; Yavuzkir M; Taskesen T; Toprak N
    J Heart Valve Dis; 2005 Nov; 14(6):735-41. PubMed ID: 16359052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of long axis M-mode echocardiographic measurements for optimum dialysis in patients on maintenance hemodialysis: comparison with changes in plasma levels of atrial natriuretic peptide and brain natriuretic peptide.
    Sugihara K; Fujimoto S; Motomiya Y; Hashimoto T; Nakamura S; Dohi K
    Clin Nephrol; 2001 Aug; 56(2):140-9. PubMed ID: 11522091
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.